Skip to content
HowShorted

HTG MOLECULAR DIAGNOSTICS, INC short interest in 2020

In 2020, HTG MOLECULAR DIAGNOSTICS, INC's disclosed short interest ran from 3.53% of shares outstanding on 15 Jan 2020 to 2.30% on 13 Nov 2020, a change of -1.23 percentage points. The year's high was 4.19% on 31 Jan 2020 and its low 0.54% on 14 Aug 2020, averaging 2.46% across 15 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 6.31 days on 14 Feb 2020. Full history: HTG MOLECULAR DIAGNOSTICS, INC.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022

Aggregate net short position time series for HTG MOLECULAR DIAGNOSTICS, INC in 2020

2020 in figures

Start of year
3.53% (15 Jan 2020)
End of year
2.30% (13 Nov 2020)
Change
-1.23 pp
High
4.19% (31 Jan 2020)
Low
0.54% (14 Aug 2020)
Average
2.46%
Highest days to cover
6.31 (14 Feb 2020)
SEC filings marked
10

Every report in 2020

HTG MOLECULAR DIAGNOSTICS, INC short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 20203.53%6.15results (8-K)
31 Jan 20204.19%3.41
14 Feb 20203.88%6.31
28 Feb 20203.73%1.66results (8-K)
13 Mar 20203.31%1.82
31 Mar 20202.77%1.2810-K filed, results (8-K)
15 Apr 20202.53%1.76
30 Apr 20202.09%1.15
15 May 20201.52%1.0010-Q filed, results (8-K)
29 May 20201.20%1.00
15 Jun 20201.27%1.00
30 Jun 20201.81%1.00
15 Jul 20202.26%1.00
14 Aug 20200.54%1.0010-Q filed, results (8-K)
13 Nov 20202.30%1.0010-Q filed, results (8-K)

See also: HTG MOLECULAR DIAGNOSTICS, INC's full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.